17+
Years of Innovation
We partner with visionary founders to leverage science and technology in creating successful businesses that address needs in India. From therapies to diagnostics to AI platforms, SciGenom provides capital and expertise to accelerate breakthrough ventures.
San Francisco, USA
Kochi, India
With domain knowledge at the forefront of SciGenom investments, start ups in our ecosystem rise to new heights.
Shared infrastructure which accelerates scientific discovery and commercialization
ThinkBio.AI is an AI software company focused on "computable biology," building platforms that integrate genomic, proteomic, and clinical data for the biopharma and healthcare sectors. Its products span drug discovery, clinical trial design, and point-of-care tools, with several AI expert agents like ThinkBio Sidney (oncology) and EMIL (immunology) launched since its founding in 2024. Headquartered in Southern California with development centres in Kochi and Trivandrum in Kerala, India, the company has a team of over 400 professionals.
RheumaCARE is positioned as India's largest rheumatology network, specializing in arthritis and autoimmune conditions. Since 2014, a multidisciplinary team of rheumatologists, pain consultants, physiotherapists, and care companions has treated disorders such as rheumatoid arthritis, lupus, ankylosing spondylitis, and vasculitis. The network has grown to cover ten Indian cities, including Bengaluru, Kochi, Ahmedabad, and Thiruvananthapuram.
Alstonia Bio, an AI-powered synthetic biology startup, was founded in 2023 in India and California. Its work spans developing new drugs and antibody-based therapies, engineering food products, and creating more sustainable biomaterials as alternatives to fossil fuels and plastics. Acquired by Simisco Biologics in 2025.
Saksin Lifesciences focused on developing affordable biologic treatments to combat adult blindness and eye diseases like wet Age-Related Macular Degeneration (AMD) and Diabetic Retinopathy. Founded in 2014 and was acquired by Theragen Life Sciences, Chennai in 2020
MagGenome is a nano-biotechnology startup that develops patented magnetic nanoparticle-based kits for nucleic acid extraction and genomics research. Its product range includes DNA/RNA extraction kits, sample collection kits, PCR cleanup beads, and protein purification products that avoid organic solvents and reduce reliance on centrifugation. Founded in 2014 and headquartered in Chennai , the company sells its products across India, the US, the Middle East, and parts of Asia.
AgriGenome specialized in next-generation DNA sequencing, genotyping, and bioinformatics services for plant, animal, and microbial projects across the agricultural, industrial, and academic sectors. R&D focused on crop improvement through TILLING and CRISPR-Cas9 genome editing, and decoding the genomes of several Indian spices, medicinal plants, and livestock. Began operations in 2015 and was sold to multiple companies on an asset sale basis in 2022.
MedGenome, established in 2013, operates South Asia's largest CAP-accredited genetic testing laboratory, offering clinically validated diagnostic assays powered by AI/ML-driven bioinformatics. Its test portfolio covers reproductive health, rare inherited disorders, oncology, and infectious diseases, having sequenced over 500,000 exomes and genomes. Headquartered in Bangalore, it partners with more than 24,000 clinicians and 8,000 hospitals across India and is the market leader for genetic diagnostics and research in India
